Corporate
TG Therapeutics Eyes $900M Revenue as BRIUMVI Takes Market Share from Roche, Novartis
Jan 14
You're signed outSign in or to get full access.
TT
TG THERAPEUTICS (TGTX)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering TG THERAPEUTICS.